Ani Pharmaceuticals Inc (ANIP)
Revenue Growth
30.90%
TTM · Period ending:
ANIP Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported30.90%period ending
Latest reported30.90%period ending
ANIP TTM Revenue YoY % (-200.00% → 30.90%)
Year-over-year change
High-resolution chart · PNG
ANIP revenue growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Revenue Growth |
|---|---|
| 30.9045% | |
| 37.0345% | |
| 43.7826% | |
| 48.8651% | |
| 38.6761% | |
| 30.2648% | |
| 26.2029% | |
| 23.6011% | |
| 34.273% | |
| 44.2622% | |
| 53.8682% | |
| 58.7505% | |
| 59.7099% | |
| 58.6496% | |
| 46.3824% | |
| 33.2408% | |
| 17.7831% | |
| 6.036% | |
| 3.6748% | |
| 6.662% | |
| 8.0133% | |
| 4.8114% | |
| 0.9334% | |
| -7.6559% | |
| -8.1472% | |
| -2.1858% | |
| 2.4661% | |
| 12.4977% | |
| 13.6722% | |
| 11.3998% | |
| 13.9865% | |
| 14.2935% | |
| 19.6551% | |
| 29.028% | |
| 37.4897% | |
| 54.6869% | |
| 75.8885% | |
| 85.3211% | |
| 68.5255% | |
| 36.7203% | |
| 17.149% | |
| 22.2452% | |
| 36.3623% | |
| 74.4727% | |
| 113.673% | |
| 80.3282% | |
| 126.9226% | |
| 182.3847% | |
| 328.8503% | |
| 1,418.9607% | |
| 972.0396% | |
| 3,497.5595% | |
| 1,510.6826% | |
| 373.7841% | |
| 428.7104% | |
| -3.5106% | |
| 56.4351% | |
| 95.7965% | |
| -82.4124% | |
| -86.3389% | |
| -90.0915% | |
| -92.7551% | |
| 96.6718% | |
| -10.7433% | |
| -13.4488% | |
| -8.366% | |
| -66.5716% | |
| 687.7308% | |
| 771.9574% | |
| 675.8046% | |
| 663.2894% | |
| -96.5999% | |
| -96.8916% | |
| -96.6119% | |
| -96.5852% | |
| 2,756.2952% | |
| 3,120.3873% | |
| 4,482.2995% | |
| 5,488.783% | |
| 129.9721% | |
| 217.4494% | |
| 216.737% | |
| 231.7027% | |
| 762.1272% | |
| 876.3057% | |
| 531.6401% | |
| 44.2227% | |
| -101.6737% | |
| -100.6238% | |
| -100.7961% | |
| -98.074% | |
| 333.4686% | |
| 5,780.4992% | |
| 288,819,400% | |
| 280,388,100% | |
| -146.4721% | |
| -200.002% |